Immediate Impact
1 by Nobel laureates 64 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Works of Ya-Ming Meng being referenced
EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ya-Ming Meng | 191 | 144 | 126 | 10 | 386 | |
| T Ogawa | 267 | 146 | 112 | 7 | 444 | |
| Peter Zentis | 178 | 131 | 96 | 11 | 421 | |
| Shican Yan | 221 | 158 | 47 | 11 | 422 | |
| Perrine Garde‐Granger | 113 | 159 | 116 | 12 | 336 | |
| Amy L. Pyle | 263 | 82 | 47 | 13 | 439 | |
| Angela M. Araujo | 242 | 137 | 106 | 9 | 446 | |
| Betül T. Yesilyurt | 182 | 184 | 57 | 9 | 435 | |
| Benjamin Schoeps | 129 | 109 | 117 | 11 | 374 | |
| Roselyne Tournaire | 285 | 125 | 58 | 11 | 446 | |
| Liam Cornell | 206 | 179 | 52 | 7 | 404 |
All Works
Login with ORCID to disown or claim papers
Loading papers...